NEW YORK, July 15, 2024 /PRNewswire/ -- The global trenbolone enanthate market size is estimated to grow by USD 13.4 million from 2024-2028,...
WESTFORD, Mass., July 15, 2024 /PRNewswire/ -- According to SkyQuest, the global Active Pharmaceutical Ingredients (API) Market size was valued at...
The rise in minimally invasive surgeries is a key driver for the global electrosurgical devices market growth, as these procedures require...
WESTFORD, Mass., July 12, 2024 /PRNewswire/ -- According to SkyQuest, the global 3D Cell Culture Market size was valued at USD...
DIEPENBEEK, Belgium and ANAHEIM, Calif. , July 12, 2024 /PRNewswire/ -- Bedal International, a Belgian based medical device company delivering next...
Marlborough, Massachusetts--(Newsfile Corp. - July 12, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) (the "Company"), a clinical stage biotechnology company...
LOUISVILLE, Ky., July 12, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a...
SAN DIEGO and SUZHOU, China, July 12, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the...
Media Release Efti in combination with KEYTRUDA® (pembrolizumab) achieved a 35.5% response rate in evaluable patients (N=31), according to RECIST...
SEATTLE, July 11, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to...
SAN DIEGO, July 11, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the...
BEIJING, July 11, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare...
BEVERLY HILLS, Calif., July 11, 2024 /PRNewswire/ -- Koning Health is excited to announce the upcoming installation of its innovative Koning...
Induced pluripotent stem cells are experiencing strong growth due to rising research into disease models and drug discovery. WILMINGTON, Del. ,...
NEW YORK, July 11, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics...
Predictive tools will seek to reduce leading cause of failure rates in clinical trials of oncology drugs. Integrated AI and...
SAN DIEGO, July 11, 2024 /PRNewswire/ -- Element Biosciences, Inc., developer of pioneering technologies to empower science, today announced over $277...
CARDIFF, UK / ACCESSWIRE / July 11, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company developing a...
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas TherapeuticsFirst instance decision on...
SALT LAKE CITY and FREMONT, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq: MYGN), a leader in...